Patent · US Active

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

US10291197B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 2, 2017
Grant dateMay 14, 2019
Priority date—
Expiry dateFeb 2, 2037

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH03F2200/451
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified forms of hemagglutinin (HA) protein including those with modified immunodominant regions and with modified maturation cleavage sites, and virus and virus-like particles containing them are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.